XML 157 R135.htm IDEA: XBRL DOCUMENT v3.25.0.1
Renasant Corporation (Parent Company Only) Condensed Financial Information - Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Assets        
Cash and cash equivalents $ 1,092,032 $ 801,351    
Accrued interest receivable on bank balances 54,395 54,804    
Other assets 300,003 304,484    
Total assets 18,034,868 17,360,535 $ 16,988,176  
Liabilities and shareholders’ equity        
Other liabilities 245,306 249,390    
Shareholders’ equity 2,678,318 2,297,383 $ 2,136,016 $ 2,209,853
Total liabilities and shareholders’ equity 18,034,868 17,360,535    
Renasant Corporation        
Assets        
Cash and cash equivalents 405,782 169,597    
Investment in bank subsidiary 2,694,503 2,541,195    
Accrued interest receivable on bank balances 27 27    
Other assets 30,726 37,268    
Total assets 3,131,038 2,748,087    
Liabilities and shareholders’ equity        
Junior subordinated debentures 113,916 112,978    
Subordinated notes 316,698 316,422    
Other liabilities 22,106 21,304    
Shareholders’ equity 2,678,318 2,297,383    
Total liabilities and shareholders’ equity 3,131,038 2,748,087    
Cash collateral $ 2,092 $ 1,987